Haemonetics is a leading global healthcare company (NYSE: HAE) founded in 1971. It is dedicated to providing innovative medical products and solutions in the biotechnology and healthcare industries, aimed at improving patient care and reducing healthcare costs. The company's focus areas include blood and plasma component collection, the surgical suite, and hospital transfusion services. Haemonetics recently secured a $600.00M Post-IPO Debt investment on 21 May 2024. For more information about Haemonetics, visit www.haemonetics.com.
Haemonetics
We make it possible. You make it matter.
Founded 1971
Boston, United States
2511 employees
Post-IPO Debt
Total: $1.75B
Biotechnology, Health Care +1
Boston, United States
2511 employees
Post-IPO Debt
Total: $1.75B
Biotechnology, Health Care +1
General Information
Company Name
Haemonetics
Founded Year
1971
Location
Boston, United States
Boston, United States
Founders / Decision Makers
Employees
2511
Industries
Biotechnology, Health Care, Medical Devices
Funding Stage
Post-IPO Debt
Social
BounceWatch is an independent company data service, not affiliated with Haemonetics. To contact Haemonetics, visit haemonetics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Haemonetics compare?
A PDF of Haemonetics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Haemonetics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Haemonetics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Haemonetics
Business keywords: medical products, blood processing technology, surgical blood salvage, diagnostic products, information technology, consulting services, interventional technologies, plasma collection, blood collection, healthcare cost reduction, global company, innovation, medical markets
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Debt | $600.00M | - |
|
21 May 2024 |
| Post IPO Equity | $435.00M | - |
|
01 Mar 2021 |
| Post IPO Equity | $10.00M | - |
|
23 May 2019 |
| Post IPO Debt | $700.00M | - |
|
18 Jun 2018 |
Haemonetics Alternatives & Competitors
View All Alternatives
Haemonetics vs
GI Windows Surgical
United States
Engineering less invasive solutions for both surgeons and patients.
Venture round
21 employees
Biotechnology, Health Care
Haemonetics vs
Biolog-id
France
The smart healthcare solution for the management and traceability of sensitive health products.
Venture round
68 employees
Analytics, Biotechnology
Haemonetics vs
Q3 Medical Group
Ireland
Creating Value By Helping People
Venture round
59 employees
Health Care, Medical Devices
Terumo Cardiovascular
HemaSource, Inc
FAQ About Haemonetics
We make it possible. You make it matter.
Haemonetics was founded in 1971.
Haemonetics is headquartered in Boston, United States.
Haemonetics operates in Biotechnology, Health Care and Medical Devices. Its work centres on medical products, blood processing technology, surgical blood salvage and diagnostic products.
Haemonetics has approximately 2511 employees.
Haemonetics has completed 4 funding rounds, raising a total of $1.75B. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Haemonetics include GI Windows Surgical, Biolog-id, Q3 Medical Group, Terumo Cardiovascular, Boston Scientific. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Haemonetics and GI Windows Surgical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Haemonetics, https://bouncewatch.com/company/haemonetics, updated 7 May 2026. When citing, please name BounceWatch and link this page.
